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Objectives : This study was performed to evaluate the
relationship between C-reactive protein (CRP) and carotid
intima-media thickness (carotid IMT) in a population of
middle-aged Koreans.
Methods : A total of 1,054 men and 1,595 women (aged
40-70 years) from Kanghwa County, Korea, were chosen
for  the present  study between 2006 and 2007.  We
measured high-sensi t iv i ty  CRP and other major
cardiovascular risk factors including anthropometrics, blood
pressure, blood chemistry, and carotid ultrasonography.
Health related questionnaires were also completed by each
study participant. Carotid IMT value was determined by the
maximal  IMT at  each common carot id ar tery.  The
relationship between CRP level and carotid IMT was
assessed using multiple linear and logistic regression
models af ter  adjustment for  age,  body mass index,
menopause (women), systolic blood pressure, total/HDL
cholesterol  rat io,  t r iglyceride level,  fast ing glucose,
smoking, and alcohol consumption. 
Results : Mean carotid IMT values from the lowest to
highest quartile of CRP were 0.828, 0.873, 0.898, and
0.926 mm for women (p for trend<0.001), and 0.929, 0.938,
0.949,  and 0.979 mm for  men (p for  t rend=0.032),
respectively. After adjustment for major cardiovascular risk
factors, the relationship between CRP and carotid IMT was
significant in women (p for trend=0.017), but not in men (p
for trend=0.798). Similarly, adjusted odds ratio of increased
IMT, defined as the sex-specific top quartile, for the highest
versus lowest CRP quartiles was 1.55 (95% CI=1.06-2.26)
in women, but only 1.05 (95% CI=0.69-1.62) in men.
Conclusions : CRP and carotid IMT levels appear to be
directly related in women, but not in men. 
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Table 1. General characteristics of study participants
Variables Men (n=1,054) Women (n=1,595)
Age, yr
Body mass index, kg/m2
Waist circumference, cm
Systolic blood pressure, mmHg
Diastolic blood pressure, mmHg
Total cholesterol, mg/dL
HDL cholesterol, mg/dL 
Triglyceride, mg/dL
Fasting glucose, mg/dL








HDL: high-density lipoprotein, IMT: intima-media thickness, hs-CRP: high-sensitivity C-reactive protein,







































0.06 - 0.41 mg/dL
II  (n=261)
0.42 - 0.75 mg/dL
III  (n=261)
0.76 - 1.58 mg/dL
IV  (n=263)
1.59 - 9.99 mg/dL
p - value p for trend
Age, yr
Waist circumference, cm
Body mass index, kg/m2
Systolic blood pressure, mmHg



































































































HDL: high-density lipoprotein, IMT: intima-media thickness, hs-CRP: high-sensitivity C-reactive protein,
Data are expressed as mean SD, median [inter-quartile range], or number (%)




0.05 - 0.35 mg/dL
II  (n=391)
0.36 - 0.67 mg/dL
III  (n=401)
0.68 - 1.35 mg/dL
IV  (n=392)
1.36 - 9.85 mg/dL
p - value p for trend
Age, yr
Waist circumference, cm
Body mass index, kg/m2
Systolic blood pressure, mmHg



































































































HDL: high-density lipoprotein, IMT: intima-media thickness, hs-CRP: high-sensitivity C-reactive protein,
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Table 4. Relationship between hs-CRP levels and carotid IMT
hs-CRP quartile
Unadjusted




































































IMT: intima-media thickness, hs-CRP: high-sensitivity C-reactive protein,
*Adjusted for age, body mass index, menopause (women), systolic blood pressure, total/HDL cholesterol ratio, triglyceride,
fasting glucose, cigarette smoking, and alcohol consumption.
Table 5. Relationship between hs-CRP levels and the risk of high carotid IMT values (highest quartile,
men 1.03 mm, women 0.95 mm)
hs-CRP quartile Unadjusted odds ratio (95% CI)
Age-adjusted odds ratio 
(95% CI)
Multivariate-adjusted*











































*Adjusted for age, body mass index, menopause (women), systolic blood pressure, total/HDL cholesterol ratio, triglyceride,
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